# Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.

> **NCT00655863** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 71 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Alogliptin and Pioglitazone
- **DRUG:** Alogliptin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00655863
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2013-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00655863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00655863, "Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00655863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*